Strata Critical Medical (SRTA) Preferred Stock Liabilities (2019 - 2021)

Strata Critical Medical (SRTA) has reported Preferred Stock Liabilities for 3 consecutive years, with $225.0 million the latest figure, recorded in Q1 2021.

• In Q1 2021, Preferred Stock Liabilities fell 10.82% year-over-year to $225.0 million; the TTM figure through Mar 2021 stood at $225.0 million (down 10.82% YoY), while the FY2020 annual figure was $226.1 million, changed N/A from the prior year.
• Preferred Stock Liabilities steadied at $225.0 million in Q1 2021 per SRTA's latest filing, from $226.1 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $252.3 million in Q1 2020 and bottomed at $225.0 million in Q1 2021.
• Historically, Preferred Stock Liabilities has averaged $241.2 million across 3 years, with a median of $244.6 million in 2020.
• Annual changes were most pronounced in 2020 — Preferred Stock Liabilities grew 0.24% — and 2021, when it fell 10.82%.
• Strata Critical Medical's Preferred Stock Liabilities stood at $246.6 million in 2019, then dropped by 8.32% to $226.1 million in 2020, then dropped by 0.48% to $225.0 million in 2021.
• Business Quant data shows SRTA's Preferred Stock Liabilities at $225.0 million in Q1 2021, $226.1 million in Q4 2020, and $244.6 million in Q3 2020.